Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Arpit Rao

Hematology Oncology | Hematology | Oncology
909 Fulton St Se, 
Minneapolis, MN 

Distinguished in WT1-Related Wilms Tumor Syndromes
909 Fulton St Se, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Arpit Rao is a Hematologist Oncology specialist and a Hematologist in Minneapolis, Minnesota. Dr. Rao is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Adult Soft Tissue Sarcoma, and Renal Cell Carcinoma (RCC).

His clinical research consists of co-authoring 22 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in MN
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

909 Fulton St Se, Minneapolis, MN 55455
Call: 612-672-7422

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Multi-arm, Phase 2 Study to Evaluate the Safety and Efficacy of Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Progressed on Second Generation AR-Directed Therapy
A Multi-arm, Phase 2 Study to Evaluate the Safety and Efficacy of Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Progressed on Second Generation AR-Directed Therapy
Enrollment Status: Active_not_recruiting
Publish Date: May 13, 2025
Intervention Type: Drug
Study Drug: IMMU-132
Study Phase: Phase 2
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
CASPAR - a Phase III Trial of Enzalutamide and Rucaparib As a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
CASPAR - a Phase III Trial of Enzalutamide and Rucaparib As a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Other, Drug
Study Drugs: Enzalutamide, Rucaparib Camsylate, Leuprolide Acetate, Goserelin Acetate, Degarelix
Study Phase: Phase 3
View 2 Less Clinical Trials

22 Total Publications

PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 23, 2024
View All 22 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Gautam G. Jha
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Gautam G. Jha
Hematology Oncology | Hematology | Oncology

Fairview Express Care

14500 99th Ave N, Suite 100, 
Maple Grove, MN 
 (16.4 miles away)
763-898-1000
Languages Spoken:
English, Hindi, Marathi
See accepted insurances
Accepting New Patients
Offers Telehealth

Gautam Jha is a Hematologist Oncology specialist and a Hematologist in Maple Grove, Minnesota. Dr. Jha is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Muscle Invasive Bladder Cancer, Urothelial Cancer, Clear Cell Sarcoma, and WT1-Related Wilms Tumor Syndromes. Dr. Jha is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Ian J. Okazaki
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Ian J. Okazaki
Hematology Oncology | Hematology | Oncology

Fairview Express Care

6401 France Ave S, 
Edina, MN 
 (7.6 miles away)
952-924-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ian Okazaki is a Hematologist Oncology specialist and a Hematologist in Edina, Minnesota. Dr. Okazaki is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Adult Soft Tissue Sarcoma, Chromophobe Renal Cell Carcinoma, and Renal Cell Carcinoma (RCC). Dr. Okazaki is currently accepting new patients.

Brian H. Rank
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Brian H. Rank
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Brian H. Rank
Hematology Oncology | Hematology | Oncology

Group Health Plan Inc

921 Greeley S St, 
Stillwater, MN 
 (20.6 miles away)
651-439-1234
Experience:
47+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brian Rank is a Hematologist Oncology specialist and a Hematologist in Stillwater, Minnesota. Dr. Rank has been practicing medicine for over 47 years and is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Adult Soft Tissue Sarcoma, and Chromophobe Renal Cell Carcinoma. Dr. Rank is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rao's expertise for a condition
ConditionClose
    • Distinguished
    • Chromophobe Renal Cell Carcinoma
      Dr. Rao is
      Distinguished
      . Learn about Chromophobe Renal Cell Carcinoma.
      See more Chromophobe Renal Cell Carcinoma experts
    • WT1-Related Wilms Tumor Syndromes
      Dr. Rao is
      Distinguished
      . Learn about WT1-Related Wilms Tumor Syndromes.
      See more WT1-Related Wilms Tumor Syndromes experts
    • Advanced
    • Adult Soft Tissue Sarcoma
      Dr. Rao is
      Advanced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Clear Cell Sarcoma
      Dr. Rao is
      Advanced
      . Learn about Clear Cell Sarcoma.
      See more Clear Cell Sarcoma experts
    • Familial Prostate Cancer
      Dr. Rao is
      Advanced
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Familial Wilms Tumor 2
      Dr. Rao is
      Advanced
      . Learn about Familial Wilms Tumor 2.
      See more Familial Wilms Tumor 2 experts
    • Prostate Cancer
      Dr. Rao is
      Advanced
      . Learn about Prostate Cancer.
      See more Prostate Cancer experts
    • Renal Cell Carcinoma (RCC)
      Dr. Rao is
      Advanced
      . Learn about Renal Cell Carcinoma (RCC).
      See more Renal Cell Carcinoma (RCC) experts
    View All 7 Advanced Conditions
    • Experienced
    • Agranulocytosis
      Dr. Rao is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • B-Cell Lymphoma
      Dr. Rao is
      Experienced
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    • Bladder Cancer
      Dr. Rao is
      Experienced
      . Learn about Bladder Cancer.
      See more Bladder Cancer experts
    • Familial Pancreatic Cancer
      Dr. Rao is
      Experienced
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Febrile Neutropenia
      Dr. Rao is
      Experienced
      . Learn about Febrile Neutropenia.
      See more Febrile Neutropenia experts
    • Lung Cancer
      Dr. Rao is
      Experienced
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    View All 17 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved